Gazette Tracker
Gazette Tracker

Core Purpose

The National Pharmaceutical Pricing Authority fixes the retail prices for various pharmaceutical formulations under the Drugs (Prices Control) Order, 2013.

Detailed Summary

The Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), through the National Pharmaceutical Pricing Authority (NPPA), issued Order S.O. 3974(E) on August 29, 2025, exercising powers under paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated May 30, 2013, and S.O. 5249(E) dated November 11, 2022. This order fixes the retail prices, exclusive of Goods and Services Tax, for 42 specific pharmaceutical formulations, detailing their strength, unit, and the name of the manufacturer and marketing company. For example, Amoxycillin & Potassium Clavulanate Oral suspension (400mg Amoxycillin / 57mg Clavulanic Acid per 5ml) is priced at Rs. 4.69 per 1 ml for M/s Copmed Pharmaceuticals Pvt. Ltd./M/s Zydus Healthcare Ltd., and Meropenem & Sulbactam for Injection (1000mg Meropenem / 500mg Sulbactam) is priced at Rs. 1938.59 per vial for M/s GMH Organics / M/s Zydus Healthcare Ltd. Manufacturers of these 'new drug' formulations must fix prices as specified, and may add Goods and Services Tax if actually paid or payable. They are required to issue a price list in Form-V to NPPA via IPDMS and submit a copy to the State Drug Controller and dealers as per paragraph 24 of DPCO, 2013. Retailers and dealers must display these price lists conspicuously. The fixed retail price is applicable only to manufacturers/marketers who applied for price fixation/revision by submitting Form-I and fulfill all statutory requirements, including manufacturing licenses. Non-compliance will result in the liability to deposit the overcharged amount with interest under the DPCO, 2013, read with the Essential Commodities Act, 1955. This order supersedes any prior price orders for the formulations and companies specified.

Full Text

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-29082025-265799 EXTRAORDINARY PART II—Section 3—Sub-section (ii) PUBLISHED BY AUTHORITY NEW DELHI, FRIDAY, AUGUST 29, 2025/BHADRA 7, 1947 5793 GI/2025 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 29th August, 2025 S.O. 3974(E). In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE +-----+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+++++++++++* REGD. No. D. L.-33004/99 CG-DL-E-29082025-265799 The Gazette of India EXTRAORDINARY PART II—Section 3—Sub-section (ii) PUBLISHED BY AUTHORITY NEW DELHI, FRIDAY, AUGUST 29, 2025/BHADRA 7, 1947 5793 GI/2025 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 29th August, 2025 S.O. 3974(E). In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | SI. | Medicines | Strength | Unit | Manufacturer & | Retail Price | | No. | | | | Marketing Company | (Rs.) | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | (1) | (2) | (3) | (4) | (5) | (6) | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Amoxycillin & | Each 5 ml of constituted | | M/s Copmed | | | | Potassium | suspension contains: | | Pharmaceuticals Pvt. Ltd./ | | | 1 | Clavulanate Oral | Amoxycillin Trihydrate IP | 1 ml | M/s Zydus Healthcare Ltd. | 4.69 | | | suspension | Equivalent to Amoxycillin 400 mg | | | | | | | Potassium Clavulanate Diluted IP | | | | | | | Equivalent to Clavulanic Acid 57 | | | | | | | mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Amoxycillin & | Each ml of the reconstituted | | M/s Malik LifeSciences Pvt. | | | | Potassium | suspension contains: | | Ltd./ | | | 2 | Clavulanate Oral | Amoxycillin Trihydrate IP | 1 ml | M/s Aurobindo Pharma Ltd. | 7.14 | | | suspension | equivalent to Amoxycillin 80 mg | | | | | | | Potassium Clavulanate Diluted IP | | | | | | | equivalent to Clavulanic Acid 11.4 | +-----------------------------------------------------------------+-----------------+ | | | mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Bilastine & | Each film coated tablet contains: | | M/s Skymap | | | 3 | Montelukast Tablets | Bilastine IP 20 mg | 1 Tablet | Pharmaceuticals Pvt. Ltd./ | 13.97 | | | | Montelukast Sodium IP equivalent | | M/s German Remedies | | | | | to Montelukast 10 mg | | Pharmaceuticals Pvt. Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Bisoprolol Fumarate | Each film coated tablet contains: | | M/s Swiss Garnier Life | | | | & Amlodipine | Bisoprolol Fumarate IP 5 mg | | sciences/ | | | 4 | tablets | Amlodipine Besylate | 1 Tablet | M/s Cadila Pharmaceuticals | 8.72 | | | | equivalent to Amlodipine IP 5 mg | | Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Calcium & Vitamin | Each film coated tablet contains: | | M/s Pure & Cure Healthcare | | | 5 | D3 tablets | Calcium Citrate Malate IP eq. to | | Pvt. Ltd./ | 12.09 | | | | Elemental Calcium 250 mg | 1 Tablet | M/s Torrent Pharmaceuticals | | | | | Vitamin D3 IP 1000 IU | | Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Cefixime & | Each film coated Sustained | | M/s Malik Lifesciences Pvt. | | | 6 | Ofloxacin (SR) | Release tablet contains: | | Ltd./ | 30.79 | | | Tablets | Cefixime IP as Trihydrate Eq. to | 1 Tablet | M/s Alkem Laboratories | | | | | Anhydrous Cefixime 400mg | | Ltd. | | | | | Ofloxacin IP 400mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Cefixime & | Each 5ml reconstituted suspension | | M/s Innova Captab Ltd. /M/s | | | 7 | Ofloxacin oral | contains: Cefixime IP as | | FDC Ltd. | 2.00 | | | suspension | Trihydrate Eq. to Anhydrous | 1 ml | | | | | | Cefixime 50mg Ofloxacin IP | | | | | | | 50mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Cefixime | Each Uncoated Dispersible Tablet | | M/s Skymap | | | 8 | Dispersible Tablets | Contains: | | Pharmaceuticals Pvt. Ltd./ | 7.56 | | | | Cefixime IP Eq. to Anhydrous | 1 Tablet | M/s German Remedies | | | | | Cefixime 100 mg | | Pharmaceuticals Pvt. Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Cefpodoxime & | Each film coated tablet contains: | | M/s Malik Lifesciences Pvt. | | | | Potassium | Cefpodoxime Proxetil IP eq. to | | Ltd./ | | | 9 | Clavulanate Tablets | Cefpodoxime 200 mg Potassium | 1 Tablet | M/s Akumentis Healthcare | 30.72 | | | | Clavulanate Diluted IP eq. to | | Ltd. | | | | | Clavulanic Acid 125 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Cholecalciferol | Each 5 ml contains: | | M/s Ravenbhel Healthcare | | | 10 | (Vitamin D3) Oral | Cholecalciferol IP (In Nano | | Pvt. Ltd./ | 15.17 | | | Solution | Droplet Form) 60,000 IU | 1 ml | M/s Zydus Healthcare Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Cilnidipine & | Each Film Coated Tablet | | M/s Pure & Cure Healthcare | | | 11 | Telmisartan Tablets | Contains: | | Pvt. Ltd./ | 17.37 | | | | Cilnidipine IP 10 mg | 1 Tablet | M/s Lupin Ltd. | | | | | Telmisartan IP 80 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Dapagliflozin, | Each film coated bilayered tablet | | M/s Akums Drugs & | | | | Glimepiride & | contains: | | Pharmaceuticals Ltd./ | | | 12 | Metformin | Dapagliflozin Propanediol USP | 1 Tablet | M/s Dr. p's Laboratories | 11.02 | | | Hydrochloride | Eq. to Dapagliflozin 10mg | | Ltd. | | | | (Extended Release) | Glimepiride IP 1 mg | | | | | | Tablets | Metformin Hydrochloride IP | | | | | | | 500mg (As Extended Release | | | | | | | Form) | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Dapagliflozin, | Each film coated bilayered tablet | | M/s Akums Drugs & | | | | Glimepiride & | contains: | | Pharmaceuticals Ltd./ | | | 13 | Metformin | Dapagliflozin Propanediol USP | 1 Tablet | M/s Dr. Reddy's | 11.81 | | | Hydrochloride | Eq. to Dapagliflozin 10mg | | Laboratories Ltd. | | | | (Extended Release) | Glimepiride IP 2 mg | | | | | | Tablets | Metformin Hydrochloride IP | | | | | | | 500mg (As Extended Release | | | | | | | Form) | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Empagliflozin & | Each film-coated tablet contains: | | M/s Windlas Biotech Ltd./ | | | 14 | Metformin | Empagliflozin 12.5 mg | 1 Tablet | M/s Systopic Laboratories | 18.10 | | | Hydrochloride | Metformin Hydrochloride IP 500 | | Pvt Ltd | | | | Tablets | mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Empagliflozin, | Each film coated bilayer tablet | | M/s Exemed | | | | Linagliptin & | contains:Linagliptin 5 mg | | Pharmaceuticals / M/s Natco | 25.00 | | 15 | Metformin | Empagliflozin 25 mg | 1 Tablet | Pharma Ltd. | | | | Hydrochloride | Metformin Hydrochloride (As | | | | | | (Extended Release) | Extended Release) IP 1000 mg | | | | | | Tablets | | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Empagliflozin, | Each film coated bilayer tablet | | M/s Exemed | | | | Sitagliptin & | contains: | | Pharmaceuticals / M/s | | | 16 | Metformin | Empagliflozin 10 mg | 1 Tablet | Cadila Pharmaceuticals Ltd. | 31.75 | | | Hydrochloride | Metformin Hydrochloride (As | | | | | | (Extended Release) | Extended Release) IP 1000mg | | | | | | Tablets | Sitagliptin Phosphate | | | | | | | Monohydrate IP Equivalent to | | | | | | | Sitagliptin 100 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Empagliflozin, | Each film coated bilayer tablet | | M/s Exemed | | | | Sitagliptin & | contains: | | Pharmaceuticals / M/s | | | 17 | Metformin | Sitagliptin Phosphate | 1 Tablet | Cadila Pharmaceuticals Ltd. | 35.29 | | | Hydrochloride | Monohydrate IP Equivalent to | | | | | | (Extended Release) | Sitagliptin 100 mg | | | | | | Tablets | Metformin Hydrochloride (As | | | | | | | Extended Release) IP 1000mg | | | | | | | Empagliflozin 25 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Empagliflozin, | Each film coated bilayer tablet | | M/s Exemed | | | | Sitagliptin & | contains: | | Pharmaceuticals/ | | | 18 | Metformin | Empagliflozin 10 mg | 1 Tablet | M/s MSN Laboratories Pvt. | 22.90 | | | Hydrochloride | Metformin Hydrochloride (As | | Ltd. | | | | | Extended Release) IP 1000 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | | (Extended Release) | | | | | | | Tablets | | | | | | | Sitagliptin Phosphate | | | | | | | Monohydrate IP Equivalent to | | | | | | | Sitagliptin 100 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Empagliflozin, | Each film coated bilayer tablet | | M/s Exemed | | | | Sitagliptin & | contains: | | Pharmaceuticals/ | | | 19 | Metformin | Sitagliptin Phosphate | 1 Tablet | M/s MSN Laboratories Pvt. | 23.90 | | | Hydrochloride | Monohydrate IP Equivalent to | | Ltd. | | | | (Extended Release) | Sitagliptin 100 mg | | | | | | Tablets | Metformin Hydrochloride (As | | | | | | | Extended Release) IP 1000mg | | | | | | | Empagliflozin 25 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Indomethacin & | Each hard gelatin capsule | | M/s Windlas Biotech Ltd./ | | | 20 | Paracetamol | contains: | 1 | M/s Micro Labs Ltd. | 6.22 | | | Capsules | Indomethacin IP (enteric coated) | Capsule | | | | | | 25mg | | | | | | | Paracetamol IP 325 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Meropenem & | Each vial contains: | | M/s GMH Organics / M/s | | | 21 | Sulbactam for | Meropenem Trihydrate IP Eq. to | | Zydus Healthcare Ltd. | 1938.59 | | | Injection | Anhydrous Meropenem 1000 mg | 1 Vial | | | | | | Sodium (as Sodium Carbonate IP) | | | | | | | 90.2 mg | | | | | | | Sulbactam Sodium IP equivalent | | | | | | | to Sulbactam 500 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Mycophenolate | Each film coated tablet contains: | | M/s Ipca Laboratories Ltd. | | | 22 | Mofetil Tablets | Mycophenolate Mofetil IP 750 | 1 Tablet | | 131.58 | | | | mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Ofloxacin & | Each 5ml contains: | | M/s Aryatech Pharma Pvt. | | | 23 | Metronidazole Oral | Ofloxacin IP 100mg | | Ltd./ | 1.04 | | | Suspension | Metronidazole Benzoate IP Eq. to | 1 ml | M/s Alkem Laboratories | | | | | Metronidazole 200mg | | Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Ofloxacin & | Each 5 ml contains: | | M/s Hema Laboratories Pvt. | | | 24 | Metronidazole | Ofloxacin IP 100 mg | | Ltd./ | 1.04 | | | Suspension | Metronidazole Benzoate IP | 1 ml | M/s Abbott Healthcare Pvt. | | | | | Equivalent to Metronidazole 200 | | Ltd. | | | | | mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Olmesartan | Each film coated tablet contains: | | M/s Windlas Biotech Ltd./ | | | | Medoxomil, | Olmesartan Medoxomil IP 40 mg | | M/s Alkem Laboratories | 20.98 | | 25 | Amlodipine & | Amlodipine Besilate IP Eq. to | 1 Tablet | Ltd. | | | | Hydrochlorothiazide | Amlodipine 5mg | | | | | | Tablets | Hydrochlorothiazide IP 12.5mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Olmesartan | Each film coated tablet contains: | | M/s Windlas Biotech Ltd./ | | | | Medoxomil, | Olmesartan Medoxomil IP 20mg | | M/s Alkem Laboratories | 15.82 | | 26 | Amlodipine & | Amlodipine Besilate IP Eq. to | 1 Tablet | Ltd. | | | | Hydrochlorothiazide | Amlodipine 5mg | | | | | | Tablets | Hydrochlorothiazide IP 12.5mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Paracetamol | Each ml contains: | | M/s Appasamy Ocular | | | 27 | Infusion | Paracetamol IP 10 mg | 1 ml | Devices Pvt. Ltd./ | 3.41 | | | | | | M/s Tyykem Pvt. Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Paracetamol, | Each film coated tablet contains: | | M/s Prosperity Drugs Pvt. | | | | Phenylephrine | Paracetamol IP 500 mg | | Ltd./ | | | 28 | Hydrochloride, | Phenylephrine Hydrochloride IP 5 | 1 Tablet | M/s Intas Pharmaceuticals | 4.49 | | | Caffeine & | mg | | Ltd. | | | | Diphenhydramine | Caffeine (anhydrous) IP 30 mg | | | | | | Hydrochloride | Diphenhydramine Hydrochloride | | | | | | Tablets | IP 25 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Povidone-Iodine & | Povidone-Iodine IP 5% W/W | | M/s Nanz Med Science | | | 29 | Metronidazole | (Available Iodine 0.5% w/w) | 1 gm | Pharma (P) Ltd./ | 3.77 | | | Ointment | Metronidazole IP 1% w/w | | M/s Mankind Prime Labs | | | | | | | Pvt. Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Ramipril & | Each film coated bilayered tablet | | M/s Akums Drugs & | | | | Extended Release | contains: | | Pharmaceuticals Ltd./M/s | | | 30 | Metoprolol | Ramipril IP 5 mg | 1 Tablet | Dr. Reddy's Laboratories | 25.78 | | | Succinate Tablets | Metoprolol Succinate IP 47.5 mg | | Ltd. | | | | | eq. to Metoprolol Tartrate 50 mg | | | | | | | (as Extended Release form) | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Rosuvastatin, | Each hard gelatin capsule | | M/s Windlas Biotech Ltd./ | | | | Aspirin & | contains: | | M/s Merck Specialities Pvt | | | 31 | Clopidogrel | Rosuvastatin Calcium IP | 1 | Ltd. | 15.61 | | | Capsules | Equivalent to Rosuvastatin 10 mg | Capsule | | | | | | (As granules) | | | | | | | Aspirin IP 75 mg (As enteric | | | | | | | coated tablets) | | | | | | | Clopidogrel Bisulphate IP | | | | | | | Equivalent to Clopidogrel 75 mg | | | | | | | (as two film coated tablets) | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Rosuvastatin, | Each hard gelatin capsule | | M/s Windlas Biotech Ltd./ | | | | Aspirin & | contains: | | M/s Merck Specialities Pvt | | | 32 | Clopidogrel | Rosuvastatin Calcium IP | 1 | Ltd. | 22.76 | | | Capsules | equivalent to Rosuvastatin 20 mg | Capsule | | | | | | (As granules) | | | | | | | Aspirin IP 75 mg (As enteric | | | | | | | coated tablets) | | | | | | | Clopidogrel Bisulphate IP | | | | | | | Equivalent to Clopidogrel 75 mg | | | | | | | (as two film coated tablets) | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Sitagliptin, | Each film coated tablet contains: | | M/s Exemed | | | | Glimepiride & | Sitagliptin Phosphate | | Pharmaceuticals/ | | | 33 | Metformin | Monohydrate IP Equivalent to | 1 Tablet | M/s Corona Remedies Pvt. | 13.27 | | | Hydrochloride | Sitagliptin 50 mg | | Ltd. | | | | Tablets | Metformin Hydrochloride IP 500 | | | | | | | mg | | | | | | | Glimepiride IP 1 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Sitagliptin, | Each film coated tablet contains: | | M/s Exemed | | | | Glimepiride & | Sitagliptin Phosphate | | Pharmaceuticals/ | | | 34 | Metformin | Monohydrate IP equivalent to | 1 Tablet | M/s Corona Remedies Pvt. | 14.95 | | | Hydrochloride | Sitagliptin 50 mg | | Ltd. | | | | Tablets | Glimepiride IP 2 mg | | | | | | | Metformin Hydrochloride IP 500 | | | | | | | mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Telmisartan & | Each film coated tablet contains: | | M/s Lifecare Formulations | | | 35 | Amlodipine Tablets | Telmisartan IP 80 mg | | Pvt. Ltd. / | 20.15 | | | | Amlodipine Besilate IP Eq. to | 1 Tablet | M/s Primus Remedies Pvt. | | | | | Amlodipine 5 mg | | Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Telmisartan & | Each uncoated Tablet contains: | | M/s Swiss Garnier Life | | | 36 | Amlodipine Tablets | Telmisartan IP 80 mg | | Sciences/ | 16.00 | | | | Amlodipine Besilate IP eq. to | 1 Tablet | M/s Workcell Solutions Pvt. | | | | | Amlodipine 5 mg | | Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Voglibose & | Each uncoated bilayered tablet | | M/s Swiss Garnier Life | | | 37 | Metformin HCl | contains: | | Sciences/ M/s Workcell | 11.61 | | | (SR) Tablets | Voglibose IP 0.3 mg | 1 Tablet | Solutions Pvt. Ltd. | | | | | Metformin Hydrochloride IP 500 | | | | | | | mg (as sustained release form) | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Cefixime & | Each 5 ml reconstituted | | M/s Alkem Healthscience | | | 38 | Ofloxacin oral | suspension contains: | | (A unit of Alkem | 1.93 | | | suspension | Cefixime Trihydrate IP equivalent | 1 ml | Laboratories Ltd.) / M/s | | | | | to Cefixime anhydrous 50 mg | | Alkem Laboratories Ltd. | | | | | Ofloxacin IP 50 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Ceftriaxone and | Each vial contains: | | M/s East African (India) | | | 39 | Tazobactam | Ceftriaxone Sodium IP equivalent | | Overseas / M/s FDC Limited | 199.26 | | | injection | to anhydrous Ceftriaxone 1000 | 1 vial | | | | | | mg | | | | | | | Tazobactam Sodium IP equivalent | | | | | | | to anhydrous Tazobactam 125mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Amlodipine & | Each film coated tablet contains: | | M/s Exemed | | | 40 | Bisoprolol Fumarate | Amlodipine Besylate IP eq. to | | Pharmaceuticals/ | 9.47 | | | Tablets | Amlodipine 2.5 mg | 1 Tablet | M/s Torrent Pharmaceuticals | | | | | Bisoprolol Fumarate IP 5 mg | | Ltd. | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Amlodipine & | Each film coated tablet contains: | | M/s Exemed | | | 41 | Bisoprolol Fumarate | Amlodipine Besylate IP eq. to | | Pharmaceuticals/M/s Torrent | 7.39 | | | Tablets | Amlodipine 2.5 mg | 1 Tablet | Pharmaceuticals Ltd | | | | | Bisoprolol Fumarate IP 2.5 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ | | Clarithromycin | Each Extended Release film | | M/s Abbott Healthcare Pvt. | | | 42 | Extended Release | coated tablet contains: | 1 Tablet | Ltd. | 71.71 | | | Tablets | Clarithromycin IP 1000 mg | | | | +-----+---------------------------------+-------------------------------------------------------------------------------------------------+----------+-----------------------------------------------------------------+-----------------+ Note: (a) The manufacturer of above-mentioned formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded. [PN/268/136/2025/F/F. No. 8(136)/2025/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054. AMAR SRIVASTAVA Date: 2025 08.29 22:53:58-4530

Never miss important gazettes

Create a free account to save gazettes, add notes, and get email alerts for keywords you care about.

Sign Up Free